Please login to the form below

Not currently logged in
Email:
Password:

RSA

This page shows the latest RSA news and features for those working in and with pharma, biotech and healthcare.

Boehringer Ingelheim and Lilly launch diabetes education campaign

The initiative includes a microsite - www.sglt.com- featuring a short educational video, Glucose Perspectives, which was created by the Royal Society for the encouragement of Arts, Manufacturing and Commerce (RSA).

Latest news

  • Life science execs concerned about UK's competitiveness

    The survey, which was sponsored by life sciences search consultancy RSA, questioned 249 senior executives from the global life sciences sector and was supported by a number of UK industry groups ... Nick Stephens, CEO of RSA, said: “These are

  • Dare to dream

    Increasingly, this means following a tight set of restrictive rules. Nick Stephens, chief executive officer of recruitment company RSA, notes that the advances in measurement tools and technology available to pharma

  • Mr Bright-side

    I am indebted to the excellent Jonathan Guthrie, the enterprise editor of the Financial Times, writing in the autumn issue of the RSA magazine, for these thoughts.

  • Commercial Lifeblood

    Through a dynamic new RSA brand, launched earlier this year, the organisation has focused on translating its new business strategy to customers. ... The RSA story highlights how important it is for senior leaders to align the brand intent (defined by an

  • Are you chicken?

    Governments and pharma must face one of their greatest ever moral challenges

More from news
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Medicines Discovery Catapult appoints CEO Medicines Discovery Catapult appoints CEO

    Currently chief executive of life sciences recruitment firm The RSA Group, Molloy will take up the lead role at the recently-established MDC in November this year. ... Molloy moves to the MDC from The RSA Group, which he joined in 2009 as a non-executive

  • RSA appoint Paul Cashman as partner for global clients RSA appoint Paul Cashman as partner for global clients

    He joins from AbbVie where he held the same role. Life sciences consultancy RSA has named Paul Cashman as partner for global clients. ... Chris Molloy, CEO at RSA, said: “We are pleased to welcome Paul to the firm.

  • RSA boosts its German speaking divisions RSA boosts its German speaking divisions

    Meanwhile Ji Kwon joins RSA as an associate consultant and will also be based in its Frankfurt offices. ... Prior to joining RSA, she was employed Odgers Berndtson, where she worked on numerous searches within Life Sciences.

  • RSA name Kris Richards as senior consultant RSA name Kris Richards as senior consultant

    Will aid the executive interims team. Life sciences recruitment firm RSA has named Kris Richards as senior consultant to the executive interims team. ... At RSA, I will be able to use all my knowledge of the sector to make meaningful and productive

  • RSA announces three new UK hires RSA announces three new UK hires

    RSA, the life sciences recruitment specialists, has made three new appointments to its team of consultants in the UK. ... Prior to joining RSA, de Bary worked for five years within life science talent management at Volt &Axess.

More from appointments
Approximately 9 fully matching, plus 4 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To transform lives through communication that changes behaviour and improves health outcomes....

Latest intelligence

Virtual Patient Engagement Program: A Customer Story
Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
Humancomms for humancare?
Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...